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Abstract 
Objective: To perform a sistematiy review of the literature about the nutritional impact 
of inflammatory bowel diseases in children and adolescents. 
Data sources: A systematic review was performed using PubMed/MEDLINE, LILAcS and 
SciELO databases, with inclusion of articles in Portuguese and in English with original 
data, that analyzed nutritional aspects of inflammatory bowel diseases in children 
and adolescents. The initial search used the terms “inflammatory bowel diseases” and 
“children” or “adolescents” and “nutritional evaluation” or “nutrition deficiency”. The 
selection of studies was initially performed by reading the titles and abstracts. Review 
studies and those withouth data for pediatric patients were excluded. Subsequently, the 
full reading of the articles considered relevant was performed.
Results: 237 studies were identified, and 12 of them were selected according to the 
inclusion criteria. None of them was performed in South America. During the analysis of 
the studies, it was observed that nutritional characteristics of patients with inflammatory 
bowel disease may be altered; the main reports were related to malnutrition, growth 
stunting, delayed puberty and vitamin D deficiency. 
Conclusion: There are nutritional consequences of inflammatory bowel diseases 
in children and adolescents, mainly growth stunting, slower pubertal development, 
underweight and vitamin deficiencies. Nutritional impairments were more significant in 
patients with crohn’s disease; overweight and obesity were more common in patients 
with ulcerative rectocolitis. A detailed nutritional assessment should be performed 
periodically in children and adolescents with inflammatory bowel disease.
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
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Introduction
Inflammatory bowel diseases (IBDs) are represented by 
ulcerative rectocolitis (URc), crohn’s disease (cD) and 
indeterminate colitis,1 which affect the gastrointestinal 
tract in different ways, mainly the ileum and other 
segments of the jejunum, very often the colon in cD and 
only the colon and/or rectum in URc. These diseases 
have overlapping clinical and pathological characteristics; 
however, some have distinct features.2,3 
There are several predisposing factors for their onset, 
such as genetic, environmental, and immunological factors, 
and an important role is played by the intestinal microbiota 
imbalance, as well as by changes in mucosal permeability 
and immune response. The risk factor to be emphasized is 
the reporting of similar cases in the family, especially in 
first-degree relatives.4,5 IBDs have a worldwide distribution, 
with increasing incidence in recent decades in all geographic 
areas, with two peaks of incidence, one in adolescence and 
another in adulthood. children are also affected, and the 
incidence in this age range is also increasing.6 
In cD there is transmural inflammation affecting any 
segment of the gastrointestinal tract, from mouth to anus, 
especially distal small intestine and colon, while URc is 
restricted to the mucosa and submucosa and can involve 
the colon and rectum. Both can have extraintestinal 
manifestations and variable severity. when clinical, 
radiological, endoscopic and histopathological criteria 
are not completely consistent, the disease is classified as 
indeterminate colitis.7,8
Nutrition is an extremely important aspect for patients 
with chronic diseases, especially in the pediatric age range. 
Nutritional problems are common in patients with IBDs, 
accompanied by clinical exacerbation of disease activity 
and remission, depending on the activity, the location, 
extension, severity and presence of complications. 
Nutritional changes can be identified in 20-85% of patients, 
especially in patients with cD.9,10 
There may be growth delay, malnutrition, 
specific micronutrient deficiencies, or eventually 
even overweight and obesity. The determinants of 
nutritional changes are: reduction of food intake, 
intestinal malabsorption, gastrointestinal losses due 
to inflammation, increased nutritional needs due to 
disease activity, concomitant infections, reduced food 
intake due to decreased appetite or due to fear of 
worsening symptoms, immunosuppressive treatment, 
side effects of medications and even surgical resections, 
and other systemic complications and involvement of 
other organs, which may cause weight loss, anemia, 
anorexia, hypoalbuminemia, negative nitrogen balance 
and nutrient and vitamin deficiencies.11-13
Repercussões nutricionais em crianças e adolescentes na presença de doenças  
inflamatórias intestinais
Resumo 
Objetivo: Realizar revisão sistemática de literatura sobre repercussões nutricionais em 
crianças e adolescentes na presença  de doenças inflamatórias intestinais. 
Fontes de dados: Realizada revisão sistemática utilizando as bases de dados PubMed/
MEDLINE, LILAcS e SciELO, com inclusão de artigos em língua portuguesa e inglesa com 
dados originais que analisaram aspectos nutricionais de crianças ou adolescentes com 
doenças inflamatórias intestinais. Na busca inicial, utilizaram-se os termos “inflamma-
tory bowel diseases” and “children” or “adolescents” and “nutritional evaluation” or 
“nutrition deficiency”. A seleção de estudos foi feita, inicialmente, por meio da leitura 
dos títulos e resumos. Foram excluídos estudos de revisão e sem resultados para faixa 
pediátrica. Em um segundo momento, foi realizada leitura completa dos artigos consi-
derados relevantes.
Síntese de dados: Foram identificados 237 estudos – desses, 12 foram selecionados de 
acordo com os critérios de inclusão, não havendo nenhum na América do Sul. Na análise 
dos artigos, foi observado que características nutricionais em pacientes com doenças 
inflamatórias intestinais podem estar alteradas, sendo relatados principalmente desnu-
trição, retardo de crescimento e puberdade e deficiência de vitamina D. 
Conclusão: Há alterações nutricionais nas doenças inflamatórias intestinais em pedia-
tria, ressaltando-se parada no crescimento e desenvolvimento puberal, baixo peso e 
deficiências vitamínicas. Os comprometimentos nutricionais relatados são mais expres-
sivos nos pacientes portadores de Doença de crohn, e sobrepeso e obesidade mais fre-
quentes na Retocolite Ulcerativa. A avaliação nutricional detalhada deve ser realizada 
periodicamente em todas crianças e adolescentes portadores de doenças inflamatórias 
intestinais.
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Figure 1 Flowchart of the systematic review of inflammatory bowel diseases in the pediatric age range and nutritional aspects
IBDs can cause manifestations of the digestive tract as 
well as extradigestive ones. These conditions also determine 
several psychosocial and economic problems, missed days 
at work and school, depression, change in body image and 
low self-esteem, sexuality and socialization difficulties, 
feeding difficulties, fear to leave the house and not finding 
a public restroom available, among others, which limit the 
quality of life. Patients also report feeding problems, a 
fact that contributes to the worsening of the nutritional 
impairment, to the development of anemia, stunted growth 
and systemic complications.14
Nutritional alterations represent public health problems, 
which affect all strata of society. IBDs can aggravate 
nutritional deficiencies, causing malnutrition, but in some 
cases they may be associated with overweight as a result 
of drugs and aspects of binge eating. Inadequate nutritional 
status is a poor prognosis and may influence treatment 
response, as well as morbidity and mortality.15,16
Nutritional assessment is of great importance for all 
pediatric patients, especially those with IBDs, allowing 
early identification of nutritional alterations, and it can be 
performed with anthropometric data, biochemical indices, 
sophisticated tests, and even through nutritional survey.18,19 
One of the most used methods is the assessment of Body 
Mass Index (BMI), calculated by dividing the patient’s 
weight by the squared height. Based on the BMI vs. age 
charts and the z score, one can classify the nutritional 
status of children.20,21 Adequate nutritional status, growth 
and development are key aspects in pediatric patients from 
the neonatal period to adolescence, particularly in patients 
with chronic diseases.
There is a scarcity of studies on nutritional assessment in 
pediatric patients with IBDs,3 and there have been no reports 
in children and adolescents in Brazil. This study aimed to 
perform a systematic review on the nutritional implications 
of the presence of IBDs in children and adolescents.
Method
To develop this study, a systematic review was performed 
in PubMed/ MEDLINE, SciELO and LILAcS databases to 
identify the literature published from January 2006 to 
January 2013, using the following terms: (Nutritional 
assessment OR nutritional disorders OR body compositions) 
AND (Inflammatory bowel diseases OR crohn disease 
OR ulcerative disease) AND (children OR pediatrics OR 
adolescents). Only studies published in Portuguese and 
English, with original data that analyzed dietary habits of 
children and adolescents with IBDs were included. Review 
studies and those with no results for pediatric patients 
were excluded.  
Study selection was initially performed by reading the 
titles and abstracts of articles. In the second phase, the 
reading of the methods section was performed, and in the 
third phase, the reading of the full texts was carried out. 
The non-relevant articles were discarded (Fig. 1). After 
analyzing and interpreting the articles, the information 
223 PubMed
articles
4 Scielo
articles
10 LILACS -
BIREME articles
237
12 duplicated articles
225
Potentially relevant articles
182 articles excluded
after analysis of
title and summary
43
31 articles excluded
by not meeting the
 inclusion criteria
12 articles
included in this study
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was organized in thematic groups. As this is a systematic 
review, it was not necessary to submit the study to the 
ethics committee for approval.
Results
After the search for published articles on the topic, the 
review identified 237 studies published during the defined 
period on the nutritional aspects of children and adolescents 
with IBDs. A total of 223 articles were found in PubMed, 
10 in LILAcS and 4 in SciELO. After exclusions, 12 articles 
were selected for final assessment, and they comprised 
this systematic review (Fig. 1). The selected studies were 
carried out in four countries: United States, United Kingdom, 
Australia and Pakistan, with nine of them having been carried 
out in the United States. There were no studies carried out 
in Brazil. The list is shown in Table 1.
Nutritional characteristics in IBds
The analyzed studies showed that pediatric IBD patients, 
especially those with cD, have alterations in nutritional 
status, and malnutrition is frequently reported. Aurangzeb 
et al22 studied 28 children with IBD and compared them 
with healthy children. The first showed lower BMI z score 
and lower weight for age (p=0.05 and p=0.01, respectively), 
and lower levels of leptin, suggesting malnutrition. Almost 
half of these children were diagnosed in the age group of 
9-12 years (prepubertal or pubertal), with the presence of 
nutritional impairment in an important phase of growth 
and development. wiskin et al23 assessed 55 children with 
IBD and found a malnutrition rate of 2.2%, according to the 
wHO criteria.
There is a tendency for underweight in patients with 
IBDs, but studies have shown some changes in that profile, 
such as an increase in the number of overweight or obese 
individuals in recent years, especially in those with URc. 
Long et al24 assessed the prevalence and epidemiology of 
obesity in 1,598 children and adolescents aged 2-18 years 
with IBD and found that 23.6% were obese or overweight. 
The study suggests that, with the advent of treatments 
for IBDs, malnutrition and underweight may cease to 
be a marker of IBD severity, with children showing high 
rates of overweight and obesity, as well as the general 
population. Kugathasan et al25 assessed 783 patients with 
IBD and showed that the majority (68%) was within the 
normal weight range, and that of the newly diagnosed 
patients with IBDs, 9-34%, depending on the type, were 
overweight – at a lower rate (7-24%), they had underweight 
or underweight risk.
Growth delay is common in patients with a diagnosis of 
IBD in childhood and this may be the only symptom. wiskin 
et al, 23 in 2011, observed growth delay in 18.2% of the 
children studied. Lee et al,26 also in 2011, assessed 295 
patients with IBD diagnosed between the ages of 1-18 years 
in a prospective cohort study and found that 22% had growth 
problems, according to the z score of height for age. The 
same authors observed a growth curve with a slight shift to 
the left in patients with IBD, while 11.3% of these patients 
had impaired final adult height. The same authors also 
found that patients with growth problems achieve lower 
mean final target height than healthy individuals.
Hood et al,27 in 2011, assessed 475 men and women with 
IBD aged 16, 18 and 20 years to evaluate the final adult height 
and found no significant differences between the height of 
patients with IBD and that of healthy individuals, despite 
the identified growth problems. These authors emphasize 
the importance of identifying patients with early growth 
retardation. Aurangzeb et al22 and Hood et al27 reported 
that those diagnosed in the prepubertal or pubertal stages 
are more vulnerable to pubertal and growth delay, and 
consequently, to a compromised final height, especially if 
the diagnosis occurs before Tanner stages 1 and 2. Thayu et 
al28 analyzed 78 patients with cD and 669 controls aged 5 to 
21 years and found older age for the same Tanner stage in 
cD patients, demonstrating that, in association with growth 
retardation, children and adolescents with IBDs often have 
pubertal delay.
Nutrient and vitamin deficiencies are reported, mainly 
vitamin D deficiency. Pappa et al,29 in 2011, assessed 
448 patients with IBD and showed that hypovitaminosis 
D is prevalent in children and adolescents. At least one 
measurement of serum 25-hydroxyvitamin D (25-OHD) was 
reported in this study and classified as optimal (>32ng/
mL), suboptimal (≤2ng/mL), insufficient (≤20ng/mL) and 
deficient (≤15ng/mL) levels. Serum 25-OHD levels less than 
optimal were reported in 58.5% of patients, and insufficient 
or deficient levels in 20.1%.
The association of vitamin D deficiency with risk 
factors is similar to that of the general population, when 
considering geographic areas with little exposure to sunlight 
at certain seasons of the year (winter and spring), dark 
skin, high BMI and lack of vitamin D supplementation, in 
addition to malabsorption of calcium and vitamin D due to 
intestinal lesion and chronic use of medications, especially 
corticosteroids. Pappa et al,30 in 2006, analyzed the status 
of vitamin D in children with IBD, in a cross-sectional study 
with 130 patients, and the prevalence of deficiency (≤15ng/
mL of 25-OHD) and severe deficiency (≤15ng/mL of 25-OHD) 
of vitamin D was present in 34.6% and 10.8%, respectively. 
Pappa et al,29 in 2011, observed lower concentrations 
of 25-OHD in young patients with active disease; in severe 
disease; in those not receiving vitamin D supplements; in 
patients with some nutritional impairment; in patients with 
newly diagnosed disease, and in those with more extensive 
disease. 
Levin et al31 analyzed serum 25-OHD levels in 78 children 
and classified them as: severe deficiency (<30nmol/L); 
moderate deficiency (<51nmol/L) and insufficiency 
(between 51 and 70 nmol/L), and found 57.5% of individuals 
with serum 25-OHD levels lower than the ideal, and 19.2% 
with moderate or severe deficiency. The authors concluded 
that newly diagnosed patients had higher mean serum 
levels of 25-OHD when compared to those with long-term 
disease, and that patients with deficiency had longer time 
of exposure to corticosteroids. Other nutritional analyses 
were performed in the selected studies.
Aurangzeb et al,22 in 2011, found mean lower levels 
of serum leptin in children with IBD when compared to 
controls, 2.4 and 5.2pg/mL, respectively. Heyman et al,32 
in 2009, found that folate levels in pediatric patients with 
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untreated IBD was higher than that obtained in healthy 
controls, although folic acid intake was higher in the 
controls. They also observed that anemia in patients with 
IBD does not depend on folate levels. Sylvester et al,33 in 
2009, found that lean mass and bone mineralization were 
significantly lower in patients with IBD, when compared to 
controls.
Nutritional assessment in pediatric patients  
with IBds
Of the 12 selected studies, almost all patients had data 
on height, weight and BMI, expressed directly or as z 
scores. Aurangzeb et al22 observed that the BMI z score and 
weight-for-age percentile in IBD patients were significantly 
lower than in controls (p<0.05 and p<0.01, respectively). 
Heyman et al32 found that the mean BMI in patients with 
IBDs was lower than in controls, but the difference was 
not significant (18.7 and 20.1kg/m² respectively, p=0.189). 
Thayu et al28 reported that patients with cD had significantly 
lower height and z scores of BMI than the control children 
(p<0.001). 
Pappa et al,29,30 in two studies (2006 and 2011), analyzed 
height, age and BMI (z scores) and observed that high BMI 
is a risk factor for low 25-OHD levels (negative association). 
Kugathasan et al25 followed the weight and height for two 
years and observed that BMI increased significantly during 
the period, reaching normal rates when compared to 
controls, but lean mass values remained lower than that 
of controls, suggesting that BMI alone is not sufficient for 
nutritional assessment in these patients, and the association 
with other methods is necessary. Kugathasan et al25 showed 
that children with normal BMI can have IBDs, especially 
URc.
crohn’s disease X Ulcerative Rectocolitis 
in Pediatric Patients
when comparing types of IBDs, there is a greater 
prevalence of nutritional impairment in patients with cD 
when compared to those with URc. Pappa et al30 observed 
that patients with cD have significantly lower mean z score 
values  of weight, height, and BMI when compared to those 
with URc (p=0.001, p=0.002 and p=0.03), as well as albumin 
values (p=0.02), suggesting greater severity in cD.
when assessing excess weight and obesity in children and 
adolescents, it was observed that despite the tendency for 
increased risk of obesity and overweight in IBD, cD patients 
had lower values  when compared to those with URc. Long 
et al24 found that the prevalence of obesity or overweight 
was 20% in patients with cD versus 30% of those with 
URc. cD patients with excess weight had higher rates of 
complications, such as IBD-related surgeries. Patients with 
URc who use corticosteroids have a greater association 
with excess weight.
Kugathasan et al25 found a prevalence of excess weight 
or obesity of approximately 10% in cD, and 20% to 30% 
in URc. The authors also observed that the BMI value at 
diagnosis depends on the type of disease, with less excess 
weight and a higher rate of malnutrition in patients 
with cD. Lee et al,26 when assessing the linear growth 
of children and adolescents with IBD, found that growth 
delay is significantly more prevalent in cD than in URc, 
with growth problems in 88% of patients with cD and only 
12% in those with URc. Unlike the previous observations, 
some studies found a higher prevalence of growth deficit 
in patients with URc. 
Pappa et al29 observed that the mean concentration 
of serum 25-OHD was 8.2% lower in patients with URc, 
when compared to those with cD, but without statistical 
significance (p=0.12). Levin et al31 observed significantly 
lower mean levels of 25-OHD (p=0.02) in patients with 
URc, when compared to cD patients with serum levels of 
54.4nmol/L and 73.1nmol/L. In the study by Heyman et 
al,32 the mean folate level was similar in patients with cD 
and URc.
discussion
The assessment of the nutritional status of children and 
adolescents with IBDs is crucial in the clinical follow-up, 
to ensure normal growth and development, to define 
appropriate drug and nutritional therapy, and promote a 
better quality of life. Another aspect is the need to prevent 
prolonged corticosteroid therapy, due to the consequent 
growth impairment.34,35 It is essential to identify nutritional 
deficiencies that usually manifest as decreased weight for 
height and/or height for age, as well as specific nutritional 
deficiencies in children and adolescents with IBDs, and 
pubertal delay in adolescents.  
Therefore, the nutritional assessment can guide the 
dietary therapy and adequate supplementation and provide 
an early correction of nutrient deficiencies, helping to 
reduce disease activity and minimize symptoms.36,37
The studies included in this review demonstrate that 
children and adolescents with IBDs, especially those 
with cD, may have nutritional impairment due to several 
factors, such as reduced food intake, malabsorption, high 
intestinal losses, increased energy expenditure due to 
chronic inflammation and medications.38,39 These effects 
can lead to problems such as malnutrition, underweight, 
growth and developmental delay, delayed onset of pubertal 
characteristics, anemia, osteopenia and osteoporosis, micro 
and macronutrient deficiencies, in addition to significant 
psychological problems related to self-image and social 
interaction with peers, difficulties in the onset of sexual 
activity and depression.40 
Other studies have shown that there is greater 
nutritional impairment in cD patients when compared to 
those with URc, as a consequence of the greater severity 
and extent of the affected area in the digestive tract. cD 
usually affects the small intestine segments responsible for 
absorption, as well as frequently affecting the colon and 
other parts of the digestive tract.35-37 Not only the extent 
of the involvement, but also the severity, presentation, 
extraintestinal manifestations and comorbidities that 
may impair the nutritional status should be taken into 
account.34,41 
If not identified and treated, malnutrition in pediatric 
patients may result in severe health problems, worsening 
prognosis and consequent reduction in immune competence, 
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increased infections, growth and development delay, 
social problems and higher rates of comorbidities. Stunted 
growth and pubertal delay are significantly important 
manifestations in pediatric patients and may be the first 
clinical findings of this condition, an aspect observed in 
several studies35-37 emphasizing the growth delay, which 
was reported in 18 to 22% of patients.
Several studies have shown high rates of growth 
retardation, often preceding the intestinal manifestations, 
ranging between 5% and 88%, with cD patients experimenting 
higher rates of nutritional impairment when compared to 
patients with URc. In association with growth retardation, 
impairment of pubertal development is observed in 20-30% 
of patients, mainly in those with cD38,41,42 of multifactorial 
etiology.35,36 
Other explanations for growth delay are associated 
with the use of medications, especially corticosteroids 
and hormonal disturbances caused by both the direct 
effects of the inflammatory processes and pubertal delay. 
children with an early diagnosis of IBD in prepubertal or 
pubertal stages deserve special attention regarding linear 
growth.35,37,42
Another aspect is the change in the overweight or 
obesity profile in the pediatric population with IBDs, with 
a tendency to the increase in the number of patients with 
overweight or obesity, ranging from 9-34%, depending on the 
disease subtype, with a higher prevalence in patients with 
URc. In a study carried out in the United States, high BMI 
was found in 20-30% of patients, with the highest values  in 
patients with ulcerative rectocolitis.41 This increase in rates 
of overweight and obesity in pediatric patients with IBDs 
may be explained, in part, by the epidemic of metabolic 
syndrome that occurs worldwide, due to changes in eating 
habits.
Studies have shown that deficiencies of minerals, 
trace elements and vitamins are common in patients 
with IBDs, with vitamin D deficiency being the most 
common, reaching 60% in some cases.41 These several 
deficiencies reflect chronic blood loss, chronic diarrhea 
or impairment of specific absorption sites, in addition 
to malabsorption due to the extent of inflammation, 
or surgical resections.34 In some studies, the most 
common deficiency was that of vitamin D in patients 
with URc, when compared to those with cD, differing 
from publications in the literature that showed a higher 
prevalence in patients with cD.38,40 
conclusions
A limited number of articles was found, and no studies on this 
subject have been carried out in South America. Nutritional 
alterations of multifactorial etiology can be found in 
inflammatory bowel diseases in children, especially growth 
and pubertal delay, underweight and vitamin deficiencies.
The reported nutritional impairments were more 
significant in patients with crohn’s disease, and overweight 
and obesity more common in ulcerative rectocolitis. A 
detailed nutritional assessment should be performed 
periodically in all children and adolescents with inflammatory 
bowel diseases, combined with different methods and 
multidisciplinary resources. More studies are needed in the 
pediatric age range with larger sample sizes.
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